You just read:

Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010

News provided by

Astellas Pharma US, Inc.

Sep 25, 2010, 07:00 ET